You are here

  • Home
  • Archive
  • Volume 65, Issue 6
  • Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators

Article info

Article menu
XML
Hepatology
Original article
Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators

Authors

  • Nguyen Dinh Van Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany German Center for Infection Research (DZIF), Hannover, Germany Institute for Molecular Biology, Medizinische Hochschule Hannover, Hannover, Germany PubMed articlesGoogle scholar articles
  • Christine S Falk Institute of Transplant Immunology, IFB-Tx, Medizinische Hochschule Hannover, Hannover, Germany PubMed articlesGoogle scholar articles
  • Lisa Sandmann Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany PubMed articlesGoogle scholar articles
  • Florian W R Vondran German Center for Infection Research (DZIF), Hannover, Germany Department of General, Visceral and Transplantation Surgery, Medizinische Hochschule Hannover, Hannover, Germany PubMed articlesGoogle scholar articles
  • Fabian Helfritz German Center for Infection Research (DZIF), Hannover, Germany Department of General, Visceral and Transplantation Surgery, Medizinische Hochschule Hannover, Hannover, Germany PubMed articlesGoogle scholar articles
  • Heiner Wedemeyer Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany German Center for Infection Research (DZIF), Hannover, Germany PubMed articlesGoogle scholar articles
  • Michael P Manns Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany German Center for Infection Research (DZIF), Hannover, Germany PubMed articlesGoogle scholar articles
  • Sandra Ciesek Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany German Center for Infection Research (DZIF), Hannover, Germany PubMed articlesGoogle scholar articles
  • Thomas von Hahn Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany German Center for Infection Research (DZIF), Hannover, Germany Institute for Molecular Biology, Medizinische Hochschule Hannover, Hannover, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sandra Ciesek, Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover 30625, Germany; Ciesek.sandra{at}mh-hannover.de
View Full Text

Citation

Van ND, Falk CS, Sandmann L, et al
Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators
Gut 2016;65:1015-1023.

Publication history

  • Received July 9, 2014
  • Revised February 11, 2015
  • Accepted February 12, 2015
  • First published March 23, 2015.
Online issue publication 
October 26, 2017

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/